“In Silico Identification of Potent FDA Approved Drugs Against Coronavirus COVID-19 Main Protease: A Drug Repurposing Approach”. Chemical Biology Letters, vol. 7, no. 3, Mar. 2020, pp. 166-75, https://pubs.thesciencein.org/journal/index.php/cbl/article/view/136.